Muhlert Nils, Sethi Varun, Cipolotti Lisa, Haroon Hamied, Parker Geoff J M, Yousry Tarek, Wheeler-Kingshott Claudia, Miller David, Ron Maria, Chard Declan
NMR Research Unit, Department of Neuroinflammation, UCL Institute of Neurology, London, UK School of Psychology and Cardiff University Brain Research Imaging Centre, Cardiff University, Cardiff, UK.
NMR Research Unit, Department of Neuroinflammation, UCL Institute of Neurology, London, UK.
J Neurol Neurosurg Psychiatry. 2015 May;86(5):530-6. doi: 10.1136/jnnp-2014-308169. Epub 2014 Jul 8.
People with multiple sclerosis (MS) have difficulties with decision-making but it is unclear if this is due to changes in impulsivity, risk taking, deliberation or risk adjustment, and how this relates to brain pathology.
We assessed these aspects of decision-making in 105 people with MS and 43 healthy controls. We used a novel diffusion MRI method, diffusion orientational complexity (DOC), as an index of grey matter pathology in regions associated with decision-making and also measured grey matter tissue volumes and white matter lesion volumes.
People with MS showed less adjustment to risk and slower decision-making than controls. Moreover, impaired decision-making correlated with reduced executive function, memory and processing speed. Decision-making impairments were most prevalent in people with secondary progressive MS. They were seen in patients with cognitive impairment and those without cognitive impairment. On diffusion MRI, people with MS showed DOC changes in all regions except the occipital cortex, relative to controls. Risk adjustment correlated with DOC in the hippocampi and deliberation time with DOC in the medial prefrontal, middle frontal gyrus, anterior cingulate and caudate parcellations and with white matter lesion volumes.
These data clarify the features of decision-making deficits in MS, and provide the first evidence that they relate to grey and white matter abnormalities seen using MRI.
多发性硬化症(MS)患者存在决策困难,但尚不清楚这是由于冲动性、冒险行为、深思熟虑或风险调整的变化所致,以及这与脑病理学有何关系。
我们评估了105例MS患者和43名健康对照者在决策方面的这些情况。我们使用了一种新的扩散磁共振成像方法,即扩散方向复杂性(DOC),作为与决策相关区域灰质病理学的指标,还测量了灰质组织体积和白质病变体积。
与对照组相比,MS患者对风险的调整较少,决策速度较慢。此外,决策受损与执行功能、记忆力和处理速度下降相关。决策障碍在继发进展型MS患者中最为普遍。在有认知障碍和无认知障碍的患者中均可见到。在扩散磁共振成像上,与对照组相比,MS患者除枕叶皮质外的所有区域均出现DOC变化。风险调整与海马体中的DOC相关,深思熟虑时间与内侧前额叶、额中回、前扣带回和尾状核中的DOC相关,并与白质病变体积相关。
这些数据阐明了MS患者决策缺陷的特征,并提供了首个证据表明这些缺陷与磁共振成像所见的灰质和白质异常有关。